Mi-eye 2, developed by Trice Medical, contains a disposable needle with a fully integrated camera, according to the report. Physicians use the device to illuminate and better visualize what’s happening inside a patient’s body during diagnostic and operative arthroscopic or endoscopic procedures.
The FDA approved the original Mi-eye device in 2014. Mi-eye 2 offers several improvements, including better resolution, field of view, depth of field and overall visualization, according to Jeffrey O’Donnel, president and CEO of King of Prussia, Penn.-based Trice Medical.
More articles on supply chain:
Novartis restructures research unit, sheds 175 jobs: 4 things to know
Insmed buys AstraZeneca’s respiratory drug for $150M: 5 things to know
FedEx to open new Ohio distribution center in 2017
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
